Health
DLnano-vaccines may be a promising strategy for cancer immunotherapy – News-Medical.Net
Researchers designed DLnano-vaccines displaying 60 copies of protein parts derived from the melanoma-specific antigens Trp2 and Gp100 and tested these in mouse models of melanoma, observing prolonged survival that depended on CD8 T cell activation both in the…
Reviewed by Emily Henderson, B.Sc.Sep 10 2020
Researchers designed DLnano-vaccines displaying 60 copies of protein parts derived from the melanoma-specific antigens Trp2 and Gp100 and tested these in mouse models of melanoma, observing prolonged survival that depended on CD8 T cell activation both in therapeutic and prophylactic settings.
One of the advantages of synthetic DNA technologies over other methods is the versatility of the platforms. DLnano-vaccines may be designed for various cance…
-
General22 hours agoYoung boy flown to Brisbane hospital after K’gari dingo attack
-
General7 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General19 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News22 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’